PMID- 12681453 OWN - NLM STAT- MEDLINE DCOM- 20030424 LR - 20190627 IS - 0002-9343 (Print) IS - 0002-9343 (Linking) VI - 114 IP - 4 DP - 2003 Mar TI - Functional class in patients with heart failure is associated with the development of diabetes. PG - 271-5 AB - PURPOSE: Recent reports suggest that decreased functional capacity in patients with heart failure may be associated with abnormalities in glucose metabolism. We followed patients with coronary artery disease who participated in the Bezafibrate Infarction Prevention study to determine the incidence of diabetes by baseline functional status during a 7.7-year follow-up. METHODS: The sample comprised 2616 nondiabetic patients aged 45 to 74 years with a fasting blood glucose level <7 mmol/L (126 mg/dL). They were divided into three groups by New York Heart Association (NYHA) criteria: class I (n = 1986 patients), class II (n = 518), and class III (n = 112). The detection of a fasting blood glucose level > or =7 mmol/L during follow-up was defined as the criterion for the development of diabetes. RESULTS: The study groups had similar demographic and clinical characteristics, except that patients with symptomatic heart failure (NYHA class II or III) were more likely to have angina. During follow-up, diabetes developed in 259 patients (13%) in NYHA class I, 76 (15%) in class II, and 22 (20%) in class III (P for trend = 0.05). At the last visit, patients in NYHA class III were twice as likely (17% [n = 19]) to have fasting blood glucose levels > or =7 mmol/L as those in NYHA class I (7.8% [n = 154]) or class II (8.7% [n = 45]) (P = 0.005). In a multivariate analysis, NYHA class III was associated with a 1.7-fold (95% confidence interval [CI]: 1.1 to 2.6) increase in the rate of development of diabetes, but NYHA class II was not (hazard ratio = 1.0; 95% CI: 0.8 to 1.3). CONCLUSION: Among patients with coronary artery disease, advanced heart failure (NYHA class III) is associated with a significantly increased risk of developing diabetes during a 6- to 9-year follow-up. FAU - Tenenbaum, Alexander AU - Tenenbaum A AD - Cardiac Rehabilitation Institute, Neufeld Cardiac Research Institute, the Chaim Sheba Medical Center, Tel-Hashomer, 52621 Israel. altenen@yahoo.com FAU - Motro, Michael AU - Motro M FAU - Fisman, Enrique Z AU - Fisman EZ FAU - Leor, Jonathan AU - Leor J FAU - Freimark, Dov AU - Freimark D FAU - Boyko, Valentina AU - Boyko V FAU - Mandelzweig, Lori AU - Mandelzweig L FAU - Adler, Yehuda AU - Adler Y FAU - Sherer, Yaniv AU - Sherer Y FAU - Behar, Solomon AU - Behar S LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - Am J Med JT - The American journal of medicine JID - 0267200 SB - IM CIN - Am J Med. 2003 Mar;114(4):331-2. PMID: 12681465 CIN - Am J Med. 2003 Oct 1;115(5):412; author reply 412. PMID: 14553881 MH - Age Distribution MH - Aged MH - Cohort Studies MH - Comorbidity MH - Confidence Intervals MH - Coronary Disease/*classification/diagnosis/*epidemiology MH - Diabetes Mellitus/diagnosis/*epidemiology MH - Female MH - Heart Failure/*classification/diagnosis/*epidemiology MH - Humans MH - Incidence MH - Male MH - Mass Screening MH - Middle Aged MH - Multivariate Analysis MH - Probability MH - Proportional Hazards Models MH - Risk Factors MH - Severity of Illness Index MH - Sex Distribution MH - Survival Analysis EDAT- 2003/04/12 05:00 MHDA- 2003/04/25 05:00 CRDT- 2003/04/12 05:00 PHST- 2003/04/12 05:00 [pubmed] PHST- 2003/04/25 05:00 [medline] PHST- 2003/04/12 05:00 [entrez] AID - S0002934302015309 [pii] AID - 10.1016/s0002-9343(02)01530-9 [doi] PST - ppublish SO - Am J Med. 2003 Mar;114(4):271-5. doi: 10.1016/s0002-9343(02)01530-9.